These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32144456)

  • 1. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
    Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrafast Dynamic Contrast-Enhanced MRI Using Compressed Sensing: Associations of Early Kinetic Parameters With Prognostic Factors of Breast Cancer.
    Kim JJ; Kim JY; Hwangbo L; Suh HB; Son Y; Nickel MD; Grimm R
    AJR Am J Roentgenol; 2021 Jul; 217(1):56-63. PubMed ID: 33909465
    [No Abstract]   [Full Text] [Related]  

  • 3. The utility of ultrafast MRI and conventional DCE-MRI for predicting histologic aggressiveness in patients with breast cancer.
    Kim SG; Park AY; Jung HK; Ko KH; Kim Y
    Acta Radiol; 2024 Oct; 65(10):1186-1195. PubMed ID: 39295306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement.
    Kim SY; Cho N; Choi Y; Shin SU; Kim ES; Lee SH; Chang JM; Moon WK
    Korean J Radiol; 2020 May; 21(5):561-571. PubMed ID: 32323501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing.
    Honda M; Kataoka M; Onishi N; Iima M; Ohashi A; Kanao S; Nickel MD; Toi M; Togashi K
    J Magn Reson Imaging; 2020 Jan; 51(1):164-174. PubMed ID: 31215107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
    Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
    J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum slope of ultrafast dynamic contrast-enhanced MRI of the breast: Comparisons with prognostic factors of breast cancer.
    Yamaguchi K; Nakazono T; Egashira R; Fukui S; Baba K; Hamamoto T; Irie H
    Jpn J Radiol; 2021 Mar; 39(3):246-253. PubMed ID: 33001328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
    He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
    Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.
    Kim JH; Park VY; Shin HJ; Kim MJ; Yoon JH
    Eur Radiol; 2022 Jul; 32(7):4823-4833. PubMed ID: 35064805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI.
    Ohashi A; Kataoka M; Iima M; Honda M; Ota R; Urushibata Y; Dominik Nickel M; Toi M; Zackrisson S; Nakamoto Y
    Eur Radiol; 2023 Nov; 33(11):8132-8141. PubMed ID: 37286791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
    Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
    Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang C; Wei W; Santiago L; Whitman G; Dogan B
    Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to enhancement of breast lesions and normal breast parenchyma in light of menopausal status and menstrual cycle for ultrafast dynamic contrast-enhanced MRI using compressed sensing.
    Yamaguchi K; Nakazono T; Egashira R; Fukui S; Baba K; Hamamoto T; Aishima S; Maruyama K; Nickel D; Irie H
    Magn Reson Imaging; 2023 Feb; 96():102-107. PubMed ID: 36375761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
    Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
    J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum slope using ultrafast breast DCE-MRI at 1.5 Tesla: a potential tool for predicting breast lesion aggressiveness.
    Pelissier M; Ambarki K; Salleron J; Henrot P
    Eur Radiol; 2021 Dec; 31(12):9556-9566. PubMed ID: 34117556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.
    Mori N; Abe H; Mugikura S; Takasawa C; Sato S; Miyashita M; Mori Y; Pineda FD; Karczmar GS; Tamura H; Takahashi S; Takase K
    Acad Radiol; 2019 Jul; 26(7):e141-e149. PubMed ID: 30269956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafast DCE-MRI for discriminating pregnancy-associated breast cancer lesions from lactation related background parenchymal enhancement.
    Nissan N; Anaby D; Mahameed G; Bauer E; Moss Massasa EE; Menes T; Agassi R; Brodsky A; Grimm R; Nickel MD; Roccia E; Sklair-Levy M
    Eur Radiol; 2023 Nov; 33(11):8122-8131. PubMed ID: 37278853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.